NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Issues Update on Efforts to Roll Out Alzheimer’s Product Hyalolex

India Globalization Capital (NYSE: IGC) today provided investors and interested parties an update on its efforts to launch its principle product for relieving the anxiety, sleep disorders and brain afflictions associated with Alzheimer’s Disease via medical cannabis dispensaries throughout the United States in the next few months. The company stated that dispensaries in Washington, D.C. … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Issues Update on Efforts to Roll Out Alzheimer’s Product Hyalolex”

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites

India Globalization Capital (NYSE American: IGC) this morning announced the launching of two new websites (www.IGCPharma.com and www.Hyalolex.com) to detail its initiatives, development timeline and pipeline of pharmaceutical cannabinoids for use in treatment of the symptoms of Alzheimer’s disease, pain, seizures and other health-related issues. Ram Mukunda, CEO of IGC, indicated in the news release … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Launches Pharmaceutical Cannabinoid Pipeline Websites”

NetworkNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Future Business Strategy

India Globalization Capital (NYSE American: IGC) is strategizing the marketing of its products and select target markets for continued growth. A recent article highlights next year’s and future year’s prospects and IGC plans, stating, “[IGC] sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex). It also sees … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc.’s (NYSE: IGC) Future Business Strategy”

India Globalization Capital, Inc. (NYSE: IGC) Enters MOU for Distribution in Germany, Plans to Commercialize Liquid Formulation of Hyalolex

IGC is scheduled to market a liquid formulation of its drug, IGC-AD1 (Hyalolex), in 2018; company is eyeing markets in Germany, Canada and U.S. states where licensed medical cannabis has been legalized IGC is exclusive licensee of a U.S. patent filing for possible THC-based Alzheimer’s disease (AD) therapy, which, if approved, could give it a … Continue reading “India Globalization Capital, Inc. (NYSE: IGC) Enters MOU for Distribution in Germany, Plans to Commercialize Liquid Formulation of Hyalolex”

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Q2 2018 Financial Results

India Globalization Capital (NYSE American: IGC) today reported financial results for the second quarter ended September 30, 2017, as well as an overview of recent operational highlights. The company’s legacy division which consists of rental of heavy equipment, commodities trading, and real estate management delivered revenue of $235,648 for the three months ended September 30, … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Q2 2018 Financial Results”

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Releases Results of Annual Shareholders Meeting

India Globalization Capital, Inc. (NYSE American: IGC) yesterday announced that during its 2016-2017 Annual Meeting of Shareholders on November 8, 2017, voting on Proposals Three and Four was adjourned to November 22, 2017 at 11:00 a.m. EST due to the lack of required stockholders needed. Stockholders of record on October 5, 2017 are eligible and … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Releases Results of Annual Shareholders Meeting”

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Regains Listing Compliance

India Globalization Capital, Inc. (NYSE American: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that it has regained NYSE American listing compliance. The company received a letter on November 9, 2017, from NYSE Regulation stating that it is currently in compliance with the NYSE American LLC continued … Continue reading “NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Regains Listing Compliance”

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates

India Globalization Capital (NYSE AMERICAN: IGC) is developing a portfolio of products using cannabis-based “combination therapies” for the treatment of various life-altering conditions. The company is employing a distinctive strategy to bring these drug candidates to market. An article discussing this reads: “IGC’s unique strategy reduces regulatory approval time and development costs because its chosen … Continue reading “NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Avoids Regulatory Costs through Cannabis-based Drug Candidates”

India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies

6 patents filed for pain management, eating disorders and epilepsy Additional patents underway for PTSD, depression, Alzheimer’s and Parkinson’s disease Revenue potential of each cannabis-based therapy could fetch between $100 million to $500 million India Globalization Capital (NYSE AMERICAN: IGC) is a first mover in developing a portfolio of products using cannabis-based “combination therapies” for … Continue reading “India Globalization Capital, Inc. (NYSE: IGC) Targets Multiple Health Concerns with Cannabis-based Therapies”

NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States

As a first mover in the cannabis-based combination therapy space, India Globalization Capital (NYSE AMERICAN: IGC) is preparing for the launch of its breakthrough treatment aimed at reducing beta-amyloid building up in Alzheimer’s patients, Hyalolex. The classification as a combination therapy enables the company to bring the product to market significantly faster than most pharmaceuticals, … Continue reading “NetworkNewsBreaks – India Globalization Capital (NYSE: IGC) Aims to Fast-Track Release of Hyalolex in Recreational Cannabis States”

Contact us: 212.418.1217